Replies to post #947 on GTC Biotherapeutics (fka GTCB)

[mblimon]

Right, in spite of what the CFO understands his company is worth. The company is worth 5 times what the share price reflects, but the man is pretty blind. The strategic moves are still very right, the pricing is akward.